Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine Acetyltransferase 6A (KAT6A) is an enzyme that functions as a histone acetyltransferase, playing a key role in chromatin remodeling and gene transcription. It is involved in various developmental processes and can act as both an oncogene and tumor suppressor depending on context. Mutations in KAT6A cause Arboleda-Tham syndrome, and aberrant expression is linked to various cancers and cognitive impairment.
Inhibition of KAT6 family enzymes (competitive with acetyl-CoA)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine Acetyltransferase 6A (KAT6A).